• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.oriP对于爱泼斯坦-巴尔病毒永生化淋巴母细胞系中EBNA基因启动子活性至关重要。
J Virol. 1996 Sep;70(9):5758-68. doi: 10.1128/JVI.70.9.5758-5768.1996.
2
B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.用缺乏Cp EBNA2增强子的爱泼斯坦-巴尔病毒突变体永生化的B细胞系倾向于利用oriP近端EBNA基因启动子Wp1。
J Virol. 1997 Dec;71(12):9134-42. doi: 10.1128/JVI.71.12.9134-9142.1997.
3
Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.通过使用从棉顶狨猴淋巴母细胞系中回收的突变型和野生型病毒,确定爱泼斯坦-巴尔病毒Cp EBNA2依赖性增强子在潜伏期建立过程中的作用。
J Virol. 2000 Dec;74(23):11115-20. doi: 10.1128/jvi.74.23.11115-11120.2000.
4
Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.在B细胞感染的初始阶段,爱泼斯坦-巴尔病毒核抗原1(EBNA1)基因的转录发生在BCR2(Cp)EBNA基因启动子诱导之前。
J Virol. 1996 Jun;70(6):3561-70. doi: 10.1128/JVI.70.6.3561-3570.1996.
5
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.爱泼斯坦-巴尔病毒核抗原1在伯基特淋巴瘤中的特异性表达源自第三个启动子,该启动子不同于潜伏感染淋巴细胞中使用的启动子。
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6550-4. doi: 10.1073/pnas.88.15.6550.
6
Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp).淋巴母细胞系中EBNA基因转录的调控:BCR2(Cp)下游序列的特征分析
J Virol. 1997 Jan;71(1):120-8. doi: 10.1128/JVI.71.1.120-128.1997.
7
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.爱泼斯坦-巴尔病毒(EBV)核抗原1 BamHI F启动子在EBV转化的B细胞进入裂解周期时被激活。
J Virol. 1992 Dec;66(12):7461-8. doi: 10.1128/JVI.66.12.7461-7468.1992.
8
Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization.删除EBNA基因启动子Wp1上游的爱泼斯坦-巴尔病毒调控序列不利于B细胞永生化。
J Virol. 2002 Nov;76(22):11763-9. doi: 10.1128/jvi.76.22.11763-11769.2002.
9
Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.病毒和细胞因子影响爱泼斯坦-巴尔病毒BCR2和BWR1启动子在不同表型细胞中的活性。
Virology. 1993 Apr;193(2):774-85. doi: 10.1006/viro.1993.1186.
10
Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.鉴定参与介导位于病毒BamHI C启动子上游的增强子的爱泼斯坦-巴尔病毒核抗原2依赖性活性的关键顺式元件。
J Virol. 1992 May;66(5):2846-52. doi: 10.1128/JVI.66.5.2846-2852.1992.

引用本文的文献

1
Characterization of a new CCCTC-binding factor binding site as a dual regulator of Epstein-Barr virus latent infection.鉴定一种新的 CCCTC 结合因子结合位点,作为 Epstein-Barr 病毒潜伏感染的双重调节子。
PLoS Pathog. 2023 Jan 25;19(1):e1011078. doi: 10.1371/journal.ppat.1011078. eCollection 2023 Jan.
2
EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.EBNA1:致癌活性、免疫逃逸及生化功能为针对爱泼斯坦-巴尔病毒相关癌症的新型治疗策略提供靶点。
Cancers (Basel). 2018 Apr 6;10(4):109. doi: 10.3390/cancers10040109.
3
Epstein-Barr virus latent genes.爱泼斯坦-巴尔病毒潜伏基因
Exp Mol Med. 2015 Jan 23;47(1):e131. doi: 10.1038/emm.2014.84.
4
Epigenetic regulation of EBV persistence and oncogenesis.EBV持续存在和肿瘤发生的表观遗传调控。
Semin Cancer Biol. 2014 Jun;26:22-9. doi: 10.1016/j.semcancer.2014.01.003. Epub 2014 Jan 24.
5
Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.动态 EBV 基因表达在 B 细胞转化过程中。
Adv Virus Res. 2014;88:279-313. doi: 10.1016/B978-0-12-800098-4.00006-4.
6
Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site. Epstein-Barr 病毒的 LMP1/LMP2 基因座的表观遗传失调是由单个 CTCF-黏合蛋白结合位点的突变引起的。
J Virol. 2014 Feb;88(3):1703-13. doi: 10.1128/JVI.02209-13. Epub 2013 Nov 20.
7
Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems.EBV-BAC 系统中,潜伏感染所需的关键顺式作用序列家族重复(FR)发生意外不稳定性。
PLoS One. 2011;6(11):e27758. doi: 10.1371/journal.pone.0027758. Epub 2011 Nov 16.
8
Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.CTCF 和 DNA 甲基转移酶 DNMT1 和 DNMT3B 对 Epstein-Barr 病毒受限潜伏期的贡献。
J Virol. 2012 Jan;86(2):1034-45. doi: 10.1128/JVI.05923-11. Epub 2011 Nov 9.
9
trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.依赖于 Epstein-Barr 病毒启动子 Wp 的潜伏期间蛋白质表达的反式抑制。
J Virol. 2011 Nov;85(21):11435-47. doi: 10.1128/JVI.05158-11. Epub 2011 Aug 24.
10
EBV latency types adopt alternative chromatin conformations.EBV 潜伏期类型采用替代的染色质构象。
PLoS Pathog. 2011 Jul;7(7):e1002180. doi: 10.1371/journal.ppat.1002180. Epub 2011 Jul 28.

本文引用的文献

1
Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.在B细胞感染的初始阶段,爱泼斯坦-巴尔病毒核抗原1(EBNA1)基因的转录发生在BCR2(Cp)EBNA基因启动子诱导之前。
J Virol. 1996 Jun;70(6):3561-70. doi: 10.1128/JVI.70.6.3561-3570.1996.
2
Molecular genetic analysis of Epstein-Barr virus Cp promoter function.爱泼斯坦-巴尔病毒Cp启动子功能的分子遗传学分析
J Virol. 1996 Mar;70(3):1695-705. doi: 10.1128/JVI.70.3.1695-1705.1996.
3
The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.爱泼斯坦-巴尔病毒永生化蛋白EBNA-2通过一种细胞增强子结合蛋白靶向DNA。
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41. doi: 10.1073/pnas.90.20.9237.
4
The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.爱泼斯坦-巴尔病毒核抗原2与末端蛋白1基因启动子的EBNA2反应性顺式元件相互作用。
EMBO J. 1993 Jan;12(1):167-75. doi: 10.1002/j.1460-2075.1993.tb05642.x.
5
An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.一种整合膜蛋白(LMP2)可阻止爱泼斯坦-巴尔病毒在表面免疫球蛋白交联后从潜伏状态重新激活。
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):772-6. doi: 10.1073/pnas.91.2.772.
6
The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.爱泼斯坦-巴尔病毒核抗原2反式激活因子通过Jκ重组信号结合蛋白被导向反应元件。
Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7568-72. doi: 10.1073/pnas.91.16.7568.
7
Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.重组信号结合蛋白Jκ对爱泼斯坦-巴尔病毒EBNA2反式激活的介导作用
Science. 1994 Jul 1;265(5168):92-5. doi: 10.1126/science.8016657.
8
Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.爱泼斯坦-巴尔病毒核蛋白2对潜伏膜蛋白1启动子的反式激活作用由Jκ和PU.1介导。
J Virol. 1995 Jan;69(1):253-62. doi: 10.1128/JVI.69.1.253-262.1995.
9
An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene.一种依赖EBNA-1的增强子在10千碱基对的距离起作用,以增加爱泼斯坦-巴尔病毒LMP基因的表达。
J Virol. 1995 Apr;69(4):2633-6. doi: 10.1128/JVI.69.4.2633-2636.1995.
10
B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.EBNA2条件性的爱泼斯坦-巴尔病毒突变体对B细胞增殖及早期G1调控蛋白的诱导作用
EMBO J. 1995 Jan 3;14(1):88-96. doi: 10.1002/j.1460-2075.1995.tb06978.x.

oriP对于爱泼斯坦-巴尔病毒永生化淋巴母细胞系中EBNA基因启动子活性至关重要。

oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.

作者信息

Puglielli M T, Woisetschlaeger M, Speck S H

机构信息

Committee on Virology of Harvard University at Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

J Virol. 1996 Sep;70(9):5758-68. doi: 10.1128/JVI.70.9.5758-5768.1996.

DOI:10.1128/JVI.70.9.5758-5768.1996
PMID:8709191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC190589/
Abstract

During Epstein-Barr virus latent infection of B lymphocytes in vitro, six viral nuclear antigens (EBNAs) are expressed from one of two promoters, Cp or Wp, whose activities are mutually exclusive. Upon infection, Wp is initially active, followed by a switch to Cp for the duration of latency. In this study, the region upstream of Cp was analyzed for the presence of cis elements involved in regulating the activities of the EBNA gene promoters in established in vitro immortalized lymphoblastoid cell lines (LCLs). It was determined that oriP, the origin for episomal maintenance during latency, is essential for efficient transcription initiation from either Cp or Wp in LCLs, as well as in some Burkitt's lymphoma cell lines. Deletion of the EBNA2-dependent enhancer located upstream of Cp resulted in a ca. two- to fivefold reduction in Cp activity in the LCLs assayed. More extensive deletion of sequences upstream of Cp, including the EBNA2-dependent enhancer, resulted in nearly complete loss of Cp activity. This loss of activity was shown to correlate with deletion of two CCAAT boxes, a proximal CCAAT box located at bp -61 to -65 and a distal CCAAT box located at bp -253 to -257, upstream of Cp. Site-directed mutagenesis of these cis elements demonstrated that Cp activity is highly dependent on the presence of a properly positioned CCAAT box, with the dependence on the distal CCAAT box apparent only when the proximal CCAAT box was deleted or mutated. Deletion of the glucocorticoid response elements located at ca. bp -850 upstream of Cp did not result in a significant loss in activity. In general, deletions which diminished Cp activity resulted in induction of Wp activity, consistent with suppression of Wp activity by transcriptional interference from Cp. The identification of oriP and the EBNA2-dependent enhancer as the major positive cis elements involved in regulating Cp activity in LCL suggests that EBNA gene transcription is largely autoregulated by EBNA 1 and EBNA 2.

摘要

在体外爱泼斯坦-巴尔病毒潜伏感染B淋巴细胞的过程中,六种病毒核抗原(EBNAs)从两个启动子之一,即Cp或Wp表达,这两个启动子的活性相互排斥。感染后,Wp最初是活跃的,随后在潜伏期间转换为Cp活跃。在本研究中,分析了Cp上游区域,以确定在已建立的体外永生化淋巴母细胞系(LCLs)中参与调节EBNA基因启动子活性的顺式元件。已确定oriP,即潜伏期间附加体维持的起源,对于LCLs以及一些伯基特淋巴瘤细胞系中从Cp或Wp进行有效的转录起始至关重要。删除位于Cp上游的EBNA2依赖性增强子导致所检测的LCLs中Cp活性约降低两到五倍。对Cp上游序列进行更广泛的删除,包括EBNA2依赖性增强子,导致Cp活性几乎完全丧失。这种活性丧失与位于Cp上游的两个CCAAT框的缺失相关,一个近端CCAAT框位于-61至-65碱基对处,一个远端CCAAT框位于-253至-257碱基对处。对这些顺式元件进行定点诱变表明,Cp活性高度依赖于一个位置合适的CCAAT框的存在,只有当近端CCAAT框被删除或突变时,对远端CCAAT框的依赖性才明显。删除位于Cp上游约-850碱基对处的糖皮质激素反应元件并未导致活性显著丧失。一般来说,降低Cp活性的缺失会导致Wp活性的诱导,这与Cp的转录干扰对Wp活性的抑制一致。将oriP和EBNA2依赖性增强子鉴定为参与调节LCL中Cp活性的主要正向顺式元件,表明EBNA基因转录在很大程度上由EBNA 1和EBNA 2自动调节。